,

Adalimumab

Measuring Adalimumab drug concentrations in patients being treated with Adalimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient.
AFIAS Adalimumab allows for reliable measurement of Adalimumab drug levels using just
a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes.
This allows clinicians to confirm the drug levels of Adalimumab immediately before the next administration.

Reviews

There are no reviews yet.

Be the first to review “Adalimumab”

Your email address will not be published. Required fields are marked *

Scroll to Top